Target intelligence / Profile preview

BMS1 pseudogene 23 (BMS1P23)

Target: BMS1P23
Molecular classification: Other, Pseudogene

Overview

BMS1 pseudogene 23 is a non-coding human pseudogene related to the BMS1 ribosome biogenesis factor but lacks evidence for protein expression, biological function, or direct involvement in disease, drug targeting, or molecular pathways. Pseudogenes such as BMS1P23 do not serve as therapeutic targets and often arise through duplication or mutation of parent genes.

Other names: BMS1P23HGNC:55088NCBI Gene: 728034Ensembl: ENSG00000286156

Beyond the preview

Go deeper on BMS1 pseudogene 23 (BMS1P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BMS1 pseudogene 23 (BMS1P23).

Explore the full profile